Datum: 8.7.2008
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Whole article on biovalley
FEBS Congress 2009
Prague, Czech Republic, July 05, 2009
Kosmetologie a nanomedicína
aneb kosmetologie není kosmetika a nanomedicína neléčí trpaslíky
Brno, Czech Republic, August 24, 2009
XXXIXth Annual Meeting of the European Society for New Methods in Agricultural Research
Brno, Czech Republic, August 25-29, 2009
Biotrans 2009
Kultur-Casino Bern, Bern, Switzerland, July 05-09, 2009
Biomechanical Design of Nanotechnological Devices for Health Care
Udine, Italy, July 06-10, 2009
International Conference on Fungal Evolution and Charles Darwin: Fom Morphology to Molecules
Pathumthani, Thailand, July 09-11, 2009
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 South Moravian Innovation Centre
Interesting biotechnology content:
Biotechnology - Biotech information at Wikipedia
Science Blogs - Blogs about science: Medicine, Biology, Physical science, ...
Nanoparticles could someday lead to end of chemotherapy
No hiding place for infecting bacteria